Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to A Latest intelligence report published by Market IntelliX, the global market for Biotech Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Biotech Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Biotech Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Monoclonal Antibodies segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Biotech Drug include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin, interferon, and monoclonal antibody (mAb) products.
This report aims to provide a comprehensive study of the global market for Biotech Drug. Report Highlights:
(1) Global Biotech Drug market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Biotech Drug market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Biotech Drug market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Biotech Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Biotech Drug segment by type and by application and regional segment by type and by application.
(6) Biotech Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Monoclonal Antibodies
Interferon
Insulin
Vaccines
Others
Market segment by application, can be divided into
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Changchun High Tech
Kanghong Pharma
Innovent Biologics
Gan&Lee
Tonghua Dongbao
United Laboratory
1 Market Overview
1.1 Product Overview and Scope of Biotech Drug
1.2 Global Biotech Drug Market Size and Forecast
1.3 China Biotech Drug Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Biotech Drug Share in Global Market, 2018-2029
1.4.2 Biotech Drug Market Size: China VS Global, 2018-2029
1.5 Biotech Drug Market Dynamics
1.5.1 Biotech Drug Market Drivers
1.5.2 Biotech Drug Market Restraints
1.5.3 Biotech Drug Industry Trends
1.5.4 Biotech Drug Industry Policy
2 Global Competitive Situation by Company
2.1 Global Biotech Drug Revenue by Company (2018-2023)
2.2 Global Biotech Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Biotech Drug Concentration Ratio
2.4 Global Biotech Drug Mergers & Acquisitions, Expansion Plans
2.5 Global Biotech Drug Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Biotech Drug Revenue by Company (2018-2023)
3.2 China Biotech Drug Biotech Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Biotech Drug, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Biotech Drug Industry Chain
4.2 Biotech Drug Upstream Analysis
4.3 Biotech Drug Midstream Analysis
4.4 Biotech Drug Downstream Analysis
5 Sights by Type
5.1 Biotech Drug Classification
5.1.1 Monoclonal Antibodies
5.1.2 Interferon
5.1.3 Insulin
5.1.4 Vaccines
5.1.5 Others
5.2 By Type, Global Biotech Drug Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Biotech Drug Revenue, 2018-2029
6 Sights by Application
6.1 Biotech Drug Segment by Application
6.1.1 Hospital
6.1.2 Retail Pharmacy
6.1.3 Other
6.2 By Application, Global Biotech Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Biotech Drug Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Biotech Drug Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Biotech Drug Market Size, 2018-2029
7.3 North America
7.3.1 North America Biotech Drug Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Biotech Drug Market Size Market Share
7.4 Europe
7.4.1 Europe Biotech Drug Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Biotech Drug Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Biotech Drug Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Biotech Drug Market Size Market Share
7.6 South America
7.6.1 South America Biotech Drug Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Biotech Drug Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Biotech Drug Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Biotech Drug Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Biotech Drug Market Size, 2018-2029
8.3.2 By Company, U.S. Biotech Drug Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Biotech Drug Market Size, 2018-2029
8.4.2 By Company, Europe Biotech Drug Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Biotech Drug Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Biotech Drug Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Biotech Drug Market Size, 2018-2029
8.5.2 By Company, China Biotech Drug Revenue Market Share, 2018-2023
8.5.3 By Type, China Biotech Drug Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Biotech Drug Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Biotech Drug Market Size, 2018-2029
8.6.2 By Company, Japan Biotech Drug Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Biotech Drug Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Biotech Drug Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Biotech Drug Market Size, 2018-2029
8.7.2 By Company, South Korea Biotech Drug Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Biotech Drug Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Biotech Drug Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Biotech Drug Market Size, 2018-2029
8.9.2 By Company, India Biotech Drug Revenue Market Share, 2018-2023
8.9.3 By Type, India Biotech Drug Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Biotech Drug Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Biotech Drug Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Biotech Drug Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Biotech Drug Models, Specifications and Application
9.1.4 Roche Biotech Drug Revenue and Gross Margin, 2018-2023
9.1.5 Roche Recent Developments
9.2 Amgen
9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
9.2.2 Amgen Company Profile and Main Business
9.2.3 Amgen Biotech Drug Models, Specifications and Application
9.2.4 Amgen Biotech Drug Revenue and Gross Margin, 2018-2023
9.2.5 Amgen Recent Developments
9.3 AbbVie
9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.3.2 AbbVie Company Profile and Main Business
9.3.3 AbbVie Biotech Drug Models, Specifications and Application
9.3.4 AbbVie Biotech Drug Revenue and Gross Margin, 2018-2023
9.3.5 AbbVie Recent Developments
9.4 Sanofi
9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position
9.4.2 Sanofi Company Profile and Main Business
9.4.3 Sanofi Biotech Drug Models, Specifications and Application
9.4.4 Sanofi Biotech Drug Revenue and Gross Margin, 2018-2023
9.4.5 Sanofi Recent Developments
9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Biotech Drug Models, Specifications and Application
9.5.4 Johnson & Johnson Biotech Drug Revenue and Gross Margin, 2018-2023
9.5.5 Johnson & Johnson Recent Developments
9.6 Pfizer
9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position
9.6.2 Pfizer Company Profile and Main Business
9.6.3 Pfizer Biotech Drug Models, Specifications and Application
9.6.4 Pfizer Biotech Drug Revenue and Gross Margin, 2018-2023
9.6.5 Pfizer Recent Developments
9.7 Novo Nordisk
9.7.1 Novo Nordisk Company Information, Head Office, Market Area and Industry Position
9.7.2 Novo Nordisk Company Profile and Main Business
9.7.3 Novo Nordisk Biotech Drug Models, Specifications and Application
9.7.4 Novo Nordisk Biotech Drug Revenue and Gross Margin, 2018-2023
9.7.5 Novo Nordisk Recent Developments
9.8 Eli Lilly
9.8.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position
9.8.2 Eli Lilly Company Profile and Main Business
9.8.3 Eli Lilly Biotech Drug Models, Specifications and Application
9.8.4 Eli Lilly Biotech Drug Revenue and Gross Margin, 2018-2023
9.8.5 Eli Lilly Recent Developments
9.9 Novartis
9.9.1 Novartis Company Information, Head Office, Market Area and Industry Position
9.9.2 Novartis Company Profile and Main Business
9.9.3 Novartis Biotech Drug Models, Specifications and Application
9.9.4 Novartis Biotech Drug Revenue and Gross Margin, 2018-2023
9.9.5 Novartis Recent Developments
9.10 Merck
9.10.1 Merck Company Information, Head Office, Market Area and Industry Position
9.10.2 Merck Company Profile and Main Business
9.10.3 Merck Biotech Drug Models, Specifications and Application
9.10.4 Merck Biotech Drug Revenue and Gross Margin, 2018-2023
9.10.5 Merck Recent Developments
9.11 Biogen
9.11.1 Biogen Company Information, Head Office, Market Area and Industry Position
9.11.2 Biogen Company Profile and Main Business
9.11.3 Biogen Biotech Drug Models, Specifications and Application
9.11.4 Biogen Biotech Drug Revenue and Gross Margin, 2018-2023
9.11.5 Biogen Recent Developments
9.12 Celltrion
9.12.1 Celltrion Company Information, Head Office, Market Area and Industry Position
9.12.2 Celltrion Company Profile and Main Business
9.12.3 Celltrion Biotech Drug Models, Specifications and Application
9.12.4 Celltrion Biotech Drug Revenue and Gross Margin, 2018-2023
9.12.5 Celltrion Recent Developments
9.13 Sobi
9.13.1 Sobi Company Information, Head Office, Market Area and Industry Position
9.13.2 Sobi Company Profile and Main Business
9.13.3 Sobi Biotech Drug Models, Specifications and Application
9.13.4 Sobi Biotech Drug Revenue and Gross Margin, 2018-2023
9.13.5 Sobi Recent Developments
9.14 3SBIO
9.14.1 3SBIO Company Information, Head Office, Market Area and Industry Position
9.14.2 3SBIO Company Profile and Main Business
9.14.3 3SBIO Biotech Drug Models, Specifications and Application
9.14.4 3SBIO Biotech Drug Revenue and Gross Margin, 2018-2023
9.14.5 3SBIO Recent Developments
9.15 Changchun High Tech
9.15.1 Changchun High Tech Company Information, Head Office, Market Area and Industry Position
9.15.2 Changchun High Tech Company Profile and Main Business
9.15.3 Changchun High Tech Biotech Drug Models, Specifications and Application
9.15.4 Changchun High Tech Biotech Drug Revenue and Gross Margin, 2018-2023
9.15.5 Changchun High Tech Recent Developments
9.16 Kanghong Pharma
9.16.1 Kanghong Pharma Company Information, Head Office, Market Area and Industry Position
9.16.2 Kanghong Pharma Company Profile and Main Business
9.16.3 Kanghong Pharma Biotech Drug Models, Specifications and Application
9.16.4 Kanghong Pharma Biotech Drug Revenue and Gross Margin, 2018-2023
9.16.5 Kanghong Pharma Recent Developments
9.17 Innovent Biologics
9.17.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position
9.17.2 Innovent Biologics Company Profile and Main Business
9.17.3 Innovent Biologics Biotech Drug Models, Specifications and Application
9.17.4 Innovent Biologics Biotech Drug Revenue and Gross Margin, 2018-2023
9.17.5 Innovent Biologics Recent Developments
9.18 Gan&Lee
9.18.1 Gan&Lee Company Information, Head Office, Market Area and Industry Position
9.18.2 Gan&Lee Company Profile and Main Business
9.18.3 Gan&Lee Biotech Drug Models, Specifications and Application
9.18.4 Gan&Lee Biotech Drug Revenue and Gross Margin, 2018-2023
9.18.5 Gan&Lee Recent Developments
9.19 Tonghua Dongbao
9.19.1 Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position
9.19.2 Tonghua Dongbao Company Profile and Main Business
9.19.3 Tonghua Dongbao Biotech Drug Models, Specifications and Application
9.19.4 Tonghua Dongbao Biotech Drug Revenue and Gross Margin, 2018-2023
9.19.5 Tonghua Dongbao Recent Developments
9.20 United Laboratory
9.20.1 United Laboratory Company Information, Head Office, Market Area and Industry Position
9.20.2 United Laboratory Company Profile and Main Business
9.20.3 United Laboratory Biotech Drug Models, Specifications and Application
9.20.4 United Laboratory Biotech Drug Revenue and Gross Margin, 2018-2023
9.20.5 United Laboratory Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Biotech Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Biotech Drug Market Restraints
Table 3. Biotech Drug Market Trends
Table 4. Biotech Drug Industry Policy
Table 5. Global Biotech Drug Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Biotech Drug Revenue Market Share by Company (2018-2023)
Table 7. Global Biotech Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Biotech Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Biotech Drug Manufacturers Product Type
Table 10. China Biotech Drug Revenue by Company (2018-2023) & (US$ million)
Table 11. China Biotech Drug Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Biotech Drug Upstream (Raw Materials)
Table 13. Global Biotech Drug Typical Customers
Table 14. Biotech Drug Typical Distributors
Table 15. By Type, Global Biotech Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Biotech Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Biotech Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Biotech Drug Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Biotech Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Biotech Drug Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Biotech Drug Revenue Market Share, 2018-2029
Table 22. Roche Company Information, Head Office, Market Area and Industry Position
Table 23. Roche Company Profile and Main Business
Table 24. Roche Biotech Drug Models, Specifications and Application
Table 25. Roche Biotech Drug Revenue and Gross Margin, 2018-2023
Table 26. Roche Recent Developments
Table 27. Amgen Company Information, Head Office, Market Area and Industry Position
Table 28. Amgen Company Profile and Main Business
Table 29. Amgen Biotech Drug Models, Specifications and Application
Table 30. Amgen Biotech Drug Revenue and Gross Margin, 2018-2023
Table 31. Amgen Recent Developments
Table 32. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 33. AbbVie Company Profile and Main Business
Table 34. AbbVie Biotech Drug Models, Specifications and Application
Table 35. AbbVie Biotech Drug Revenue and Gross Margin, 2018-2023
Table 36. AbbVie Recent Developments
Table 37. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 38. Sanofi Company Profile and Main Business
Table 39. Sanofi Biotech Drug Models, Specifications and Application
Table 40. Sanofi Biotech Drug Revenue and Gross Margin, 2018-2023
Table 41. Sanofi Recent Developments
Table 42. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 43. Johnson & Johnson Company Profile and Main Business
Table 44. Johnson & Johnson Biotech Drug Models, Specifications and Application
Table 45. Johnson & Johnson Biotech Drug Revenue and Gross Margin, 2018-2023
Table 46. Johnson & Johnson Recent Developments
Table 47. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 48. Pfizer Company Profile and Main Business
Table 49. Pfizer Biotech Drug Models, Specifications and Application
Table 50. Pfizer Biotech Drug Revenue and Gross Margin, 2018-2023
Table 51. Pfizer Recent Developments
Table 52. Novo Nordisk Company Information, Head Office, Market Area and Industry Position
Table 53. Novo Nordisk Company Profile and Main Business
Table 54. Novo Nordisk Biotech Drug Models, Specifications and Application
Table 55. Novo Nordisk Biotech Drug Revenue and Gross Margin, 2018-2023
Table 56. Novo Nordisk Recent Developments
Table 57. Eli Lilly Company Information, Head Office, Market Area and Industry Position
Table 58. Eli Lilly Company Profile and Main Business
Table 59. Eli Lilly Biotech Drug Models, Specifications and Application
Table 60. Eli Lilly Biotech Drug Revenue and Gross Margin, 2018-2023
Table 61. Eli Lilly Recent Developments
Table 62. Novartis Company Information, Head Office, Market Area and Industry Position
Table 63. Novartis Company Profile and Main Business
Table 64. Novartis Biotech Drug Models, Specifications and Application
Table 65. Novartis Biotech Drug Revenue and Gross Margin, 2018-2023
Table 66. Novartis Recent Developments
Table 67. Merck Company Information, Head Office, Market Area and Industry Position
Table 68. Merck Company Profile and Main Business
Table 69. Merck Biotech Drug Models, Specifications and Application
Table 70. Merck Biotech Drug Revenue and Gross Margin, 2018-2023
Table 71. Merck Recent Developments
Table 72. Biogen Company Information, Head Office, Market Area and Industry Position
Table 73. Biogen Company Profile and Main Business
Table 74. Biogen Biotech Drug Models, Specifications and Application
Table 75. Biogen Biotech Drug Revenue and Gross Margin, 2018-2023
Table 76. Biogen Recent Developments
Table 77. Celltrion Company Information, Head Office, Market Area and Industry Position
Table 78. Celltrion Company Profile and Main Business
Table 79. Celltrion Biotech Drug Models, Specifications and Application
Table 80. Celltrion Biotech Drug Revenue and Gross Margin, 2018-2023
Table 81. Celltrion Recent Developments
Table 82. Sobi Company Information, Head Office, Market Area and Industry Position
Table 83. Sobi Company Profile and Main Business
Table 84. Sobi Biotech Drug Models, Specifications and Application
Table 85. Sobi Biotech Drug Revenue and Gross Margin, 2018-2023
Table 86. Sobi Recent Developments
Table 87. 3SBIO Company Information, Head Office, Market Area and Industry Position
Table 88. 3SBIO Company Profile and Main Business
Table 89. 3SBIO Biotech Drug Models, Specifications and Application
Table 90. 3SBIO Biotech Drug Revenue and Gross Margin, 2018-2023
Table 91. 3SBIO Recent Developments
Table 92. Changchun High Tech Company Information, Head Office, Market Area and Industry Position
Table 93. Changchun High Tech Company Profile and Main Business
Table 94. Changchun High Tech Biotech Drug Models, Specifications and Application
Table 95. Changchun High Tech Biotech Drug Revenue and Gross Margin, 2018-2023
Table 96. Changchun High Tech Recent Developments
Table 97. Kanghong Pharma Company Information, Head Office, Market Area and Industry Position
Table 98. Kanghong Pharma Company Profile and Main Business
Table 99. Kanghong Pharma Biotech Drug Models, Specifications and Application
Table 100. Kanghong Pharma Biotech Drug Revenue and Gross Margin, 2018-2023
Table 101. Kanghong Pharma Recent Developments
Table 102. Innovent Biologics Company Information, Head Office, Market Area and Industry Position
Table 103. Innovent Biologics Company Profile and Main Business
Table 104. Innovent Biologics Biotech Drug Models, Specifications and Application
Table 105. Innovent Biologics Biotech Drug Revenue and Gross Margin, 2018-2023
Table 106. Innovent Biologics Recent Developments
Table 107. Gan&Lee Company Information, Head Office, Market Area and Industry Position
Table 108. Gan&Lee Company Profile and Main Business
Table 109. Gan&Lee Biotech Drug Models, Specifications and Application
Table 110. Gan&Lee Biotech Drug Revenue and Gross Margin, 2018-2023
Table 111. Gan&Lee Recent Developments
Table 112. Tonghua Dongbao Company Information, Head Office, Market Area and Industry Position
Table 113. Tonghua Dongbao Company Profile and Main Business
Table 114. Tonghua Dongbao Biotech Drug Models, Specifications and Application
Table 115. Tonghua Dongbao Biotech Drug Revenue and Gross Margin, 2018-2023
Table 116. Tonghua Dongbao Recent Developments
Table 117. United Laboratory Company Information, Head Office, Market Area and Industry Position
Table 118. United Laboratory Company Profile and Main Business
Table 119. United Laboratory Biotech Drug Models, Specifications and Application
Table 120. United Laboratory Biotech Drug Revenue and Gross Margin, 2018-2023
Table 121. United Laboratory Recent Developments
List of Figure
Figure 1. Biotech Drug Picture
Figure 2. Global Biotech Drug Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Biotech Drug Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Biotech Drug Market Share of Global
Figure 5. Global Biotech Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Biotech Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Biotech Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Biotech Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Biotech Drug Industry Chain
Figure 10. Monoclonal Antibodies
Figure 11. Interferon
Figure 12. Insulin
Figure 13. Vaccines
Figure 14. Others
Figure 15. By Type, Global Biotech Drug Revenue, 2018-2029, US$ Million
Figure 16. By Type, Global Biotech Drug Revenue Market Share, 2018-2029
Figure 17. Hospital
Figure 18. Retail Pharmacy
Figure 19. Other
Figure 20. By Application, Global Biotech Drug Revenue, 2018-2029, US$ Million
Figure 21. By Application, Global Biotech Drug Revenue Market Share, 2018-2029
Figure 22. By Region, Global Biotech Drug Revenue Market Share, 2018-2029
Figure 23. North America Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Biotech Drug Revenue Market Share, 2018-2023
Figure 25. Europe Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Biotech Drug Revenue Market Share, 2018-2023
Figure 27. Asia Pacific Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Biotech Drug Revenue Market Share, 2018-2023
Figure 29. South America Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Biotech Drug Revenue Market Share, 2018-2023
Figure 31. Middle East & Africa Biotech Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 33. By Company, U.S. Biotech Drug Market Share, 2018-2023
Figure 34. By Type, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 36. Europe Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 37. By Company, Europe Biotech Drug Market Share, 2018-2023
Figure 38. By Type, Europe Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 39. By Application, Europe Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 40. China Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 41. By Company, China Biotech Drug Market Share, 2018-2023
Figure 42. By Type, China Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 43. By Application, China Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 44. Japan Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 45. By Company, Japan Biotech Drug Market Share, 2018-2023
Figure 46. By Type, Japan Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 47. By Application, Japan Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 48. South Korea Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 49. By Company, South Korea Biotech Drug Market Share, 2018-2023
Figure 50. By Type, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 51. By Application, South Korea Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 52. Southeast Asia Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 53. By Company, Southeast Asia Biotech Drug Market Share, 2018-2023
Figure 54. By Type, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 55. By Application, Southeast Asia Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 56. India Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 57. By Company, India Biotech Drug Market Share, 2018-2023
Figure 58. By Type, India Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 59. By Application, India Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 60. Middle East & Asia Biotech Drug Revenue, 2018-2029, (US$ Million)
Figure 61. By Company, Middle East & Asia Biotech Drug Market Share, 2018-2023
Figure 62. By Type, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 63. By Application, Middle East & Asia Biotech Drug Revenue Market Share, 2022 VS 2029
Figure 64. Research Methodology
Figure 65. Breakdown of Primary Interviews
Figure 66. Bottom-up Approaches
Figure 67. Top-down Approaches
Research Methodology:
Biotech Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|